Call it the Zombie Market, if you will, a staggering, stumbling, somnambulant thing of macabre beauty that sustains slings, arrows and shotgun blasts but still marches forward.
Jeff Kleintop, chief market strategist at LPL Financial, is more succinct and culturally aware: He calls it the "Walking Dead" market, after the wildly popular, zeitgeist-y AMC zombie series.
Instead of the perils zombies face to survive in a post-Apocalyptic world, the "walkers" of Wall Street must fend off the many macro and micro economic threats to their existence.
(Read more: Ten bets from top hedge fund managers)
Negligible economic growth? No sweat. Recession in Europe? Nobody cares. China slowdown? Big deal. Near-zero revenue growth? Someone else's problem. Federal Reserve tapering? Who needs 'em?
Kleintop bemoans the lack of Emmy nominations for "Walking Dead," and said the stock market,—like the shows zombies—doesn't get enough credit for defying its many detractors.
"This unkillable stock market rally seems to get no respect. U.S. stocks have been snubbed by investors this year," he said. "The S&P 500 has continued the strongest bull market since WWII despite all the shots fired at the market this year."
In addition to the aforementioned zombie-slayers, he also cited the "fiscal cliff" tax increases and sequestration spending cuts in Congress; zooming oil prices, European debt woes; rising interest rates, geopolitical turmoil and low market participation.
(Read more: While the traders are away, the bulls will play)